KD Logo

Tag: NTLA

Stock Earnings

NTLA stock rated a Neutral by Goldman

Intellia Therapeutics Inc’s filing revealed that its VP, Chief Accounting Officer Dube Michael P unloaded Company’s shares for reported $16711.0